Advancing cooperation on health technology assessment (HTA) and supporting the implementation of the new EU legal framework on HTA
[New] Patient input and healthcare professional input requested for second medical device Joint Clinical Assessment.
EUnetHTA 21 is pleased to announce it has started a second Joint Clinical Assessment on a medical device. The technology under assessment is a device
Patient input and healthcare professional input requested for first medical device Joint Clinical Assessment
EUnetHTA 21 is pleased to announce it has started a Joint Clinical Assessment on a medical device for male patients with urinary symptoms associated with
EUnetHTA 21-EMA Bilateral Meeting Minutes available now.
We are pleased to announce the publication of the EUnetHTA 21 – EMA bilateral meeting minutes. The joint meeting was held in June 2022. It
Updated documents for Joint Scientific Consultations (JSCs) now available.
The Guidance on Parallel EMA/EUnetHTA 21 JSC and the Briefing Book Template have been updated and are now available on the EUnetHTA 21 JSC website:
The 2nd Open Call for Joint Scientific Consultations (JSCs) closed and new products for the 2nd batch of parallel EMA/EUnetHTA 21 JSC have been selected
The EUnetHTA 21 2nd Open Call for applications from the pharmaceutical industry for Joint Scientific Consultations (JSCs) closed on 31 August, 2022. The EUnetHTA 21
Public consultation for D4.4 Endpoints is now open until 1.11.2022.
EUnetHTA 21 announces that the public consultation for the draft deliverable D4.4 Endpoints is open until 1.11.2022, 23:59 CEST. The draft deliverable as well as
Joint HTA Work
EUnetHTA develops several services that help inform the decision-making process around the introduction of pharmaceuticals and other technologies at the national, regional, and European levels. These include Joint Scientific Consultations, Parallel Consultations, and Post Launch Evidence Generation (PLEG). Find out more here.
Tools
EUnetHTA has developed a suite of tools to complement all steps in the collaborative joint work process, helping partners to proceed with a defined methodology. Access all current and archived tools here.
COVID-19 Response
EUnetHTA has prioritised COVID-19-related initiatives above other work during the current time. Here you will find updated information and publications relating to COVID-19 diagnostic testing, therapeutic treatments, and useful links to further data from our network partners.
Get Involved
EUnetHTA functions as a collaboration between network members and exterior partners to develop joint work. These include patients, industry, regulators, HCPs, and payers. Find out more about partner involvement, activities, and EUnetHTA events here.
